Journal of Molecular Medicine

Herausgeber

Springer

International Standard Serial Number (ISSN )

0946-2716

ISSN gedruckt

0946-2716

Weitere Details

2020

HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD.

2020

Regimen-dependent synergism and antagonism of treprostinil and vildagliptin in hematopoietic cell transplantation.

2020

S100A4 mRNA-protein relationship uncovered by measurement noise reduction.

2018

Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction.

2015

miR-375 gene dosage in pancreatic 13-cells: implications for regulation of β-cell mass and biomarker development

2013

Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome.

2002

A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: a phase I/II study.

1999

Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study.

Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format

2020

HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD.

2020

Regimen-dependent synergism and antagonism of treprostinil and vildagliptin in hematopoietic cell transplantation.

2020

S100A4 mRNA-protein relationship uncovered by measurement noise reduction.

2018

Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction.

2015

miR-375 gene dosage in pancreatic 13-cells: implications for regulation of β-cell mass and biomarker development

2013

Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome.

2002

A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: a phase I/II study.

1999

Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study.

Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format